<DOC>
	<DOCNO>NCT00162214</DOCNO>
	<brief_summary>The purpose Segment 1 study determine effect ketoconazole dasatinib . The purpose Segment 2 learn dasatinib affect tumor growth patient advance solid tumor .</brief_summary>
	<brief_title>Study Dasatinib Patients With Advanced Solid Tumors</brief_title>
	<detailed_description />
	<mesh_term>Ketoconazole</mesh_term>
	<mesh_term>Dasatinib</mesh_term>
	<criteria>ECOG status 02 Advanced metastatic disease , unresponsive standard treatment ( standard treatment exists ) Biopsy pretreatment Adequate bone marrow , liver kidney function Serious cardiovascular disease Bleeding disorder Gastrointestinal ( GI ) tract disease Platelet inhibitor H2 blocker , proton pump inhibitor</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Advanced Solid Tumors</keyword>
</DOC>